A phase III study of Dupilumab in chronic obstructive pulmonary disease (COPD)
Phase of Trial: Phase II/III
Latest Information Update: 07 Jan 2019
At a glance
- Drugs Dupilumab (Primary)
- Indications Chronic obstructive pulmonary disease
- Focus Registrational; Therapeutic Use
- 07 Jan 2019 According to a Regeneron media release, the company expects to initiate this study in 2019.
- 07 Feb 2018 According to a Sanofi media release, this study is planned to initiate in Q4 2018.
- 18 Dec 2017 New trial record